PrimaryCareNOW: A Pri-Med Virtual Conference | Pri-Med

Thank you to all who joined us live for PrimaryCareNOW on Wednesday-Thursday, March 16–17. If you were not able to join us live, some sessions have been recorded and are available below. 

Upcoming Virtual Conferences 
Pri-Med has more virtual education planned. View the schedule here.

Plan Your CME/CE Experiences

 

Agenda

  CME/CE Accredited Session

Non-CME/CE Session
Sponsored by Industry

Click For Session Details
Session Times Listed in ET

8–9am ET    CME/CE Accredited Session

Infectious Disease

 

Since the pandemic, there has been an increase in the number of individuals who have developed post-covid-19-related symptoms (many symptoms lasting weeks or month and the persons are identified as "long haulers").

Igor Koralnik, MD, FAAN, FANA

Archibald Church Professor of Neurology, Chief, Division of Neuro-Infectious Diseases & Global Neurology, Davee Department of Neurology, Director, Global Neurology Program, Global Health Institute, Feinberg School of Medicine, Northwestern University, Chicago, IL

9:10–10:10am ET    CME/CE Accredited Session

Neurology

First Contact - Headache in Primary Care 

Shivang Joshi, MD, MPH, RPh, FAHS | Maureen Moriarty, DNP, ANP-BC, FAHS, FAANP

 

Migraine affects 1 in 7 people worldwide and is the second leading cause of all global disability. Primary care practitioners are often the first contact for patients with migraine, yet it can be challenging to distinguish migraine from other headache disorders and remain current on best practices for management. Tune in to this session, developed by the American Headache Society as part of the First Contact – Headache in Primary Care initiative to learn strategies for accurate and timely identification of migraine and review updates to management.

Default Biography Avatar

Shivang Joshi, MD, MPH, RPh, FAHS

Associate Professor Clinical Pharmacy Practice and, Headache Specialist of Buffalo School of Pharmacy, DENT Neurologic Institute

Default Biography Avatar

Maureen Moriarty, DNP, ANP-BC, FAHS, FAANP

Associate for Moriarity Associates:, A Comprehensive Headache Center

10:20–11:05am ET    Non-CME Industry Theater

Endocrinology

Shifting Perspectives: How Do You Choose the Next Oral Therapy for T2D?

Doron Schneider, MD, FACP, MBA

 

Review the pathophysiology of T2D and the recommendations from relevant associations on the oral treatment options that should be used after metformin in the T2D treatment plan. Discuss head-to-head data for a once-daily treatment option from pivotal glycemic control trials and safety data from a cardiovascular outcomes trial, followed by dosing and administration information.

Doron Schneider, MD, FACP, MBA

Vice President, Clinical Strategy, Tandigm Health, West Conshohocken, PA

Sponsored by Novo Nordisk

10:20–11:05am ET    Non-CME Industry Theater

Cardiology

Ted Okerson, MD, FACP, FACE

 

  • Understand the risk factors that contribute to the elevated risk for thrombotic cardiovascular events pre- and post-myocardial infarction in patients across the coronary artery disease spectrum.
  • Differentiate oral P2Y12 inhibitors with respect to their clinical pharmacology and examine the select differences between oral antiplatelet therapies.
  • Describe the role of BRILINTA in reducing the risk of cardiovascular events in patients with acute coronary syndrome, history of myocardial infarction, and high-risk coronary artery disease without prior myocardial infarction.

Ted Okerson, MD, FACP, FACE

Dr. Okerson currently serves as a Sr. Field Physician within the Biopharmaceuticals US Medical Team for AstraZeneca’s Division of Cardiovascular and Metabolic Diseases. Dr. Okerson has a diverse medical and scientific background, with over 15 years of full-time clinical practice and leadership experience. For the past twenty years, he has exemplified a successful transition to industry, working as a Medical Director in various aspects of the pharmaceutical industry from clinical trial design to late phase clinical development and medical affairs for various well-known companies. In his current role, Dr. Okerson educates HCPs, works across specialties for internal collaborations, and strives to improve patient care.

Sponsored by  AstraZeneca Pharmaceuticals, LP

11:15am–12:45pm ET    CME/CE Accredited Session

Cardiology

Ask the Experts in Cardiology: Hypertension and Heart Failure

Karol E. Watson, MD, PhD | Ty J. Gluckman, MD, FACC, FAHA

 

Get your questions answered by expert faculty in cardiology, with a focus on hypertension and heart failure. You will learn practical solutions to common clinical challenges and tips to apply the latest knowledge in practice.

Karol E. Watson, MD, PhD

Professor of Medicine/Cardiology, David Geffen School of Medicine at UCLA, Co-director, UCLA Program in Preventive Cardiology, David Geffen School of Medicine at UCLA, Director, UCLA Barbra Streisand Women's Heart Health Program, David Geffen School of Medicine at UCLA, Los Angeles, CA

Ty J. Gluckman, MD, FACC, FAHA

Medical Director, Center for Cardiovascular Analytics, Research, and Data Science (CARDS), Providence Heart Institute, Providence St. Joseph Health, Portland, OR

12:55–1:40pm ET    Non-CME Industry Theater

Pulmonology

Rethinking the Role of Nebulization in the Maintenance Treatment of COPD

Ryan D. Reber, DO

 

Join us to learn about a maintenance therapy for the treatment of COPD.

Ryan D. Reber, DO

Chief of Pulmonary and Critical Care Medicine, Medical Director, Intensive Care Unit, Paoli Hospital

Clinical Assistant Professor of Medicine, Sidney Kimmel Medical College of Thomas Jefferson University

Sponsored by Viatris and Theravance Biopharma

1:50–2:50pm ET    CME/CE Accredited Session

Hot Topics

How to Approach Unexpected Test Results in Primary Care: Patient Case Examples

Amy Clouse, MD

 

We all have those slightly abnormal, entirely unexpected or just unfamiliar lab results that we are not quite sure how to handle. In this 60-minute session, we will review 5 common patient scenarios where the results, whether blood, urine, or radiologic, may have been unexpected and the work up can often be controversial or unclear. Learn practical and evidence-based management plans for abnormal liver tests, subclinical hypothyroidism, microscopic hematuria, and trichomonas infections on Pap tests. 

Amy Clouse, MD

Clinical Associate Professor of Family and Community Medicine, Sidney Kimmel Medical College at Thomas Jefferson University, Associate Residency Director, Abington – Jefferson Health Family Medicine Residency Program, Abington, PA

3–4pm ET    CME/CE Accredited Session

Dermatology

Updates in Dermatology – Common Rashes

Avery LaChance, MD, MPH

 

Get an update and overview on this presentation on the diagnosis, work up, and management of common inflammatory skin disease followed by an open Q&A period.

Avery LaChance, MD, MPH

Director, Connective Tissue Disease Clinic, Director, Health Policy and Advocacy, Assistant Professor in Dermatology, Harvard Medical School

4:10–4:55pm ET    Non-CME Industry Theater

Rheumatology

Path To Diagnosis, Mapping Symptoms of Inflammatory Back Pain

Christopher Parker, DO

 

  • Understand the causes and prevalence of chronic low back pain.
  • Differentiate inflammatory back pain (IBP) from mechanical back pain.
  • Learn the significance of IBP as a potential early symptom of ankylosing spondylitis (AS).
  • Learn the importance of referring patients with IBP to a rheumatologist in a timely manner.

Christopher Parker, DO

Sponsored by AbbVie

8–9am ET    CME/CE Accredited Session

Pulmonology

Curbside Consults: Top Questions From PCPs on Pneumonia and Polypharmacy 

Nicola Hanania, MD, MS, FCCP, FACP, FRCP (C) | Lee A. Lindquist, MD, MPH, MBA

 

What do primary care providers need to know about pneumonua and polypharmacy? Join expert faculty as they review important questions they get asked about these topics!

Nicola Hanania, MD, MS, FCCP, FACP, FRCP (C)

Associate Professor of Medicine , Director, Airways Clinical Research Center, , Section of Pulmonary, Critical Care and , Sleep Medicine Baylor College of Medicine, Houston, TX

Lee A. Lindquist, MD, MPH, MBA

Chief of Geriatrics, Northwestern University, Feinberg School of Medicine, Chicago, IL

9:10–10:10am ET    CME/CE Accredited Session

Neurology

What Primary Care Clinicians Need to Know About Alzheimer’s Disease: Early Diagnosis, Patient-Specific Management, and Care Collaboration

Richard S. Isaacson, MD | Charles Vega, MD, FAAFP

 

Are you frequently challenged by the task of early and accurate diagnosis of Alzheimer’s disease (AD) as a PCP? Are you keen to the possibility of collaboration with secondary care specialists to optimize early recognition and management of AD? Are you up to date on the latest developments and clinical pearls of Alzheimer’s research in order to tailor patient-specific approaches for AD? This live virtual meeting will examine these challenges and provide effective strategies to meet them head on.

This session will provide you with the latest information regarding the role of PCPs and their extended care team in early diagnosis of AD, effective methods to address racial and ethnic barriers to dementia-related care, and important clinical pearls to encourage collaboration among PCPs and secondary care specialists. In addition, learn the intricacies surrounding patient-specific management considerations, as well as the role of recently approved and emerging disease-modifying therapies for the management of AD.

Richard S. Isaacson, MD

Director, Center for Brain Health, Director, Alzheimer’s Prevention Clinic, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL, Adjunct Associate Professor of Neurology, Department of Neurology, Weill Cornell Medicine/NewYork-Presbyterian, New York City, NY

Charles Vega, MD, FAAFP

Health Sciences Clinical Professor, UC Irvine Department of Family Medicine, Assistant Dean for Culture and Community Education, Executive Director, UC Irvine Program in Medical Education for the Latino Community, UC Irvine School of Medicine, Irvine, CA

Supported by Eisai

10:20–11:05am ET    Non-CME Industry Theater

Pulmonology

The Changing Treatment Landscape for Uncontrolled Asthma

Susan Kuchera Fidler, MD

 

This session will use a case presentation to discuss the impact of uncontrolled asthma and tools for assessing asthma control as well as asthma management. Learn to identify ways to customize management of uncontrolled asthma by exploring medication options for appropriate patients.

Susan Kuchera Fidler, MD

Associate Director Family Medicine Residency, Abington Family Medicine – Jefferson Health, Jenkintown, PA, Clinical Assistant Professor of Family and Community Medicine, Sidney Kimmel Medical College

Sponsored by GlaxoSmithKline

10:20–11:05am ET    Non-CME Industry Theater

Infectious Disease

James Q. Del Rosso, DO, FAOCD, FAAD

 

This session will provide an overview of onychomycosis including causative agents as well as the role mail physiology plays in effectiveness of treatments.  The role of both topical and oral products will be examined as well as presentation on the role of JUBLIA (Efinaconazole) Topical Solution 10% for the treatment of onychomycosis.

Resources

James Q. Del Rosso, DO, FAOCD, FAAD

Dr. Del Rosso has been in clinical practice of dermatology for 35 years, 25 years in Las Vegas, Nevada. He has completed research, several teaching initiatives and presentations at major medical meetings, and has many publications in dermatology, with many on nail disorders including onychomycosis and antifungal therapy.

He is past president of the Council for Nail Disorders and is currently the Research Director and Principal Investigator at JDR Dermatology Research Las Vegas, Nevada and Senior Vice President of Clinical Research Strategic Development at Advanced Dermatology & Cosmetic Surgery in Maitland, Florida.

He also serves as Clinical Editor in Chief of the Journal of Clinical and Aesthetic Dermatology, a position he has held since the inception of the journal over a decade ago.

Sponsored by Bausch Health, US. LLC

11:15am–12:15pm ET    CME/CE Accredited Session

Infectious Disease

New Recommendations for Pneumococcal Immunizations: Taking Action, Protecting Patients

Rachel Caskey, MD, MAPP | Robert H. Hopkins, Jr., MD, MACP, FAAP

 

The CDC Advisory Committee on Immunization Practices (ACIP) has completely revised the recommendations for pneumococcal immunization in adults for 2022. The change was made possible by the approval of 2 new conjugate vaccines that cover pneumococcal serotypes that significantly contribute to the burden of invasive pneumococcal disease. This is important because some individuals, including older adults or those with certain chronic medical conditions or immunocompromising conditions, are at increased risk for pneumococcal disease and its serious, sometimes life-threatening complications.

Rachel Caskey, MD, MAPP

Associate Professor of Pediatrics and Internal Medicine, Chief of Academic Internal Medicine, University of Illinois at Chicago, Chicago, IL

Robert H. Hopkins, Jr., MD, MACP, FAAP

Professor of Internal Medicine and Pediatrics, University of Arkansas for Medical Sciences College of Medicine, Little Rock, AR

Supported by Merck & Co. Inc.

12:25–1:25pm ET    CME/CE Accredited Session

Nephrology

Curbside Consults: Top Questions from PCPs on Hematuria and CKD 

Melanie Hoenig, MD | Rajeev Raghavan, MD

 

What do primary care providers need to know about hematuria and CKD? Join nephrologist Dr. Melanie Hoenig and nephrologist Dr. Rajeev Raghavan as they review important questions they get asked about these topics!

Melanie Hoenig, MD

Associate Professor, Harvard Medical School, Boston, MA

Rajeev Raghavan, MD

Internal Medicine Program Director, HCA Houston Healthcare, Clinical Professor of Medicine, University of Houston

1:35–2:20pm ET    Non-CME Industry Theater

Pulmonology

Atypical Asthma in Primary Care: Differential Diagnostic Consideration of Alpha-1

Purvi Parikh, MD

 

This educational program will focus on asthma, including atypical and moderate to severe cases which Primary Care Providers may encounter in clinical practice. Differentiation of less common etiologies, such as alpha-1 antitrypsin deficiency, will be reviewed.

Purvi Parikh, MD

Clinical Assistant Professor of Medicine and Pediatrics, New York University School of Medicine, Attending Physician, Allergy & Immunology, Allergy and Asthma Associates of Murray Hill, NYU Langone Medical Center, New York, New York

Sponsored by Takeda Pharmaceuticals U.S.A., Inc.

2:30–3:30pm ET    CME/CE Accredited Session

Endocrinology

Managing Obesity in Primary Care Practice 

Fatima Cody Stanford, MD, MPH, MPA, MBA, FAAP, FACP, FAHA, FAMWA, FTOS

 

Obesity is the most prevalent chronic disease of the modern era in the U.S. and around the world, affecting both the adult and pediatric population. Although many believe that helping patients to achieve a healthy weight is of minimal complexity, weight regulation and management is a challenging endeavor. In this talk, Dr. Cody Stanford will explore the complexities of obesity and offer a range of strategies (behavioral, therapeutic, and surgical) to help you in the quest to address overweight and obesity in your practice.

Fatima Cody Stanford, MD, MPH, MPA, MBA, FAAP, FACP, FAHA, FAMWA, FTOS

Obesity Medicine Physician Scientist, Massachusetts General Hospital, Obesity Medicine Physician Scientist, Harvard Medical School, Boston, MA

3:40–4:40pm ET    CME/CE Accredited Session

Ophthalmology

A Toolbox to Help Triage Urgent Ophthalmic Conditions

Lauren S. Blieden, MD

 

Ophthalmologic emergencies can have profound consequences, and it can be challenging for PCPs to determine which cases require urgent referral. This session will provide you with a toolbox of tips and strategies to help triage urgent ophthalmic conditions in your practice.

Lauren S. Blieden, MD

Associate Professor & Vice-Chair, of Education, Cullen Eye Institute, Baylor College of Medicine,, Houston, TX

4:50–5:35pm ET    Non-CME Industry Theater

Cardiology

Clinical Insights in VTE: Treatment and Reduction in the Risk of Recurrent DVT/PE

Robert Takla, MD

 

This lecture will discuss the Treatment and Reduction in the Risk of Recurrent DVT/PE, Whether Initiated in the Inpatient or Outpatient Setting.

Robert Takla, MD

Sponsored by Janssen Pharmaceuticals, Inc.